Skip to main content

Table 2 Mean and standard deviations for outcome parameters with mean group differences and 95%CI for FACT-G, FACIT-F, TOI FACIT-F, and Total FACIT-F between cycles with fasting and regular diet of group A and B at day 8 after chemotherapy

From: The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study

Descriptives
Group Cycle N Mean Std. Deviation 95% Confidence Interval for Mean Mean difference Statistical significance
Lower Bound Upper Bound
FACT-G Group A first half of a 4–6 cycle 52 71.1 18.7 65.9 76.3 9.2 0.041
second half of a 4–6 cycle 27 61.9 18.5 54.6 69.2
FACT-G Group B first half of a 4–6 cycle 46 76.0 17.2 70.9 81.1 2 0.576
second half ofa 4–6 cycle 47 74.0 17.6 68.8 79.2
FACIT-F (FS) Group A first half of a 4–6 cycle 52 33.9 13.4 30.2 37.6 9.1 0.006
second half of a 4–6 cycle 27 24.8 13.7 19.4 30.2
FACIT-F (FS) Group B first half of a 4–6 cycle 46 33.4 14.0 29.3 37.6 1.8 0.521
second half of a 4–6 cycle 47 31.7 12.6 28.0 35.4
FACIT-F TOI Group A first half of a 4–6 cycle 52 66 25 59 72.9 16.2 0.009
second half of a 4–6 cycle 27 49.8 26.4 39.4 60.3
FACIT-F TOI Group B first half of a 4–6 cycle 46 68.0 25.2 60.5 75.5 4.2 0.41
second half of a 4–6 cycle 47 63.8 23.9 56.8 70.8
FACIT-F Total Group A first half of a 4–6 cycle 52 105 30.4 96.6 113.5 18.3 0.013
second half of a 4–6 cycle 27 105 30.5 74.6 98.8
FACIT-F Total Group B first half of a 4–6 cycle 46 109.5 29.8 100.6 118.3 4.2 0.531
second half of a 4–6 cycle 47 105.7 28.3 97.3 114.0